| 
Healthcare & Pharmaceuticals

Steve Shor, Founder of the National Children's Leukemia Foundation (NCLF), a leading non-profit organization in the United States, and National Program Director Dr. Sara Gardin will address an entire delegation of prominent executives at Frost & Sullivan’s inaugural launch of its premier global congress on Growth, Innovation and Leadership – GIL 2012: Russia.  During the address, a monumental discovery in cancer research will be presented as announced for the first time on 9 May 2012 in London, UK.

It remains the world’s worst nuclear accident and according to one report may have already claimed the lives of nearly one million people but, despite happening over twenty-five years ago, its toxic and deadly legacy still remains.

The Chernobyl disaster in April 1986 occurred when a series of explosions at the nuclear power plant in Ukraine released large amounts of radioactive material into the atmosphere, affecting many areas in Europe and former Soviet republics.

 

The EBRD has agreed to buy a minority equity stake of around 15 per cent in Russia’s privately-held OJSC Katren, the holding vehicle for pharmaceutical distributors operating in Russia, Ukraine , Kazakhstan and Belarus, as well as a retail pharmacy chain in Russia, according to EBRD.

Russia´s state nanotechnology corporation Rusnano will spend $300 million to develop a newly-created international biopharmaceutical company Pro Bono Bio (PBB), with British investment fund Celtic Pharma being the other party to the deal.

The new company, with its headquarters both in Moscow and London, will focus on the development of innovative medicines in a such areas as hematology, endocrinology, cardiology, oncology, and neurology, as well asfight combat infectious diseases. According to the official statement, the British party will mostly be responsible for expertise and experience, while Rusnano will provide for necessary financing through its subsidiary Rusnano Capital. Also, Russia will soon have state of the art production facilities, the release adds.

Andrew Sibley, carpet maker Desso's regional sales and marketing director, looks at occupational asthma in Russia and the role of carpeting in improving indoor air quality.

 

Modern evidence suggests we cannot separate our working lives from the working environment. We respond instinctively to our surroundings at a human level and if those surroundings fail to meet our basic needs, we can be made sick by them. It even has a name: Sick Building Syndrome (SBS).

Russian scientists have developed the world's first early-warning blood clot detector, the Rossiiskaya Gazeta paper said on Wednesday. According to the newspaper, the device has been successfully tested in the United States and France and its production could begin in 2012.

«StartPrev12NextEnd»
Page 1 of 2